Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation

Transplantation

Volumn 96, Issue 10, 2013, Pages 926-934

  Gehrau, Ricardo C ^a   Mas, Valeria R ^a   Dumur, Catherine I ^b   Ladie, Danielle E ^a   Suh, Jihee L ^a   Luebbert, Samuel ^a   Maluf, Daniel G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Gene expression; Ischemia reperfusion injury; Liver transplantation; Microarray; MicroRNA

Indexed keywords

CXCL2 CHEMOKINE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MICRORNA; MICRORNA 100; MICRORNA 100 5P; MICRORNA 125; MICRORNA 125B 5P; MICRORNA 139 5P; MICRORNA 16 5P; MICRORNA 185 5P; MICRORNA 192 3P; MICRORNA 21; MICRORNA 223 3P; MICRORNA 30C; MICRORNA 331; MICRORNA 3621; MICRORNA 532 3P; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL ABUSE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HEPATITIS C; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN TARGETING; REPERFUSION INJURY;

ADULT; AGED; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; POSTOPERATIVE PERIOD; REPERFUSION INJURY; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84891826079     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a20398     Document Type: Article

References (49)

1. Matesanz R, Mahillo B, Alvarez M, et al. Global observatory and database on donation and transplantation: world overview on transplantation activities. Transplant Proc 2009; 41: 2297.
2. Dienstag JL, Cosimi AB. Liver transplantationVa vision realized. N Engl J Med 2012; 367: 1483.
3. Briceno J, Ciria R. Early graft dysfunction after liver transplantation. Transplant Proc 2010; 42: 631.
4. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 2010; 97: 1461.
5. de Rougemont O, Dutkowski P, Clavien PA. Biological modulation of liver ischemia-reperfusion injury. Curr Opin Organ Transplant 2010; 15: 183.
6. Totsuka E, Fung JJ, Hakamada K, et al. Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc 2004; 36: 1955.
7. Moore DE, Feurer ID, Speroff T, et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005; 140: 273.
8. Furukawa H, Taniguchi M, Fujiyoshi M, et al. Japanese Study Group of Liver Transplantation. Experience using extended criteria donors in first 100 cases of deceased donor liver transplantation in Japan. Transplant Proc 2012; 44: 373.
9. Totsuka E, Fung U, Hakamada K, et al. Analysis of clinical variables of donors and recipients with respect to short-term graft outcome in human liver transplantation. Transplant Proc 2004; 36: 2215.
10. Wang MF, Jin ZK, Chen DZ, et al. Risk factors of severe ischemic biliary complications after liver transplantation. Hepatobil Pancreat Dis Int 2011;10: 374.
11. Gastaca M. Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors. Transplant Proc 2012; 44: 1545.
12. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
13. Natori S, Selzner M, Valentino KL, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspasedependent mechanism. Transplantation 1999; 68: 89.
14. Adeyi O, Fischer SE, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. J Clin Pathol 2010; 63: 47.
15. Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am 2010; 90: 665.
16. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immunemediated tissue inflammation. Am J Transplant 2011; 11: 1563.
17. Weigand K, Brost S, Steinebrunner N, et al. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg 2012; 2012: 176723.
18. Eltzschig HK, Eckle T. Ischemia and reperfusionVfrom mechanism to translation. Nat Med 2011; 17: 1391.
19. Ikemura K, Yamamoto M, Miyazaki S, et al. MicroRNA-145 posttranscriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells. Mol Pharmacol 2013; 83: 399.
20. Chassin C, Hempel C, Stockinger S, et al. MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol Med 2012; 4: 1308.
21. Aguado-Fraile E, Ramos E, Saenz-Morales D, et al. miR-127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 target. PLoS One 2012; 7: e44305.
22. Zhang L, Dong LY, Li YJ, et al. The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor. J Neuroinflamm 2012; 9: 211.
23. Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012; 142: 1431.
24. Gehrau RC, Mas VR, Maluf DG. Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs? Expert Rev Gastroenterol Hepatol 2013; 7: 157.
25. Minor T, Paul A. Hypothermic reconditioning in organ transplantation. Curr Opin Organ Transplant 2013; 18: 161.
26. Henry SD, Nachber E, Tulipan J, et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 2012; 12: 2477.
27. Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012; 18: 290.
28. Xu CF, Yu CH, Li YM. Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice. OMICS 2009; 13: 513.
29. Raschzok N, Werner W, Sallmon H, et al. Temporal expression profiles indicate a primary function for microRNA during the peak of DNA replication after rat partial hepatectomy. Am J Physiol Regul Integr Comp Physiol 2011; 300: R1363.
30. Chen X, Murad M, Cui YY, et al. miRNA regulation of liver growth after 50% partial hepatectomy and small size grafts in rats. Transplantation 2011; 91: 293.
31. Chaveles I, Zaravinos A, Habeos IG, et al. MicroRNA profiling in murine liver after partial hepatectomy. Int J Mol Med 2012; 29: 747.
32. Zhu Q,Wang Z, Hu Y, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 2012; 27: 1660.
33. Yu CH, Xu CF, Li YM. Association of microRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci 2009; 54: 2362.
34. Conti A, Scala S, D'Agostino P, et al. Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation. Liver Transpl 2007; 13: 99.
35. Jassem W, Fuggle S, Thompson R, et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver Transpl 2009; 15: 1750.
36. Borozan I, Chen L, Sun J, et al. Gene expression profiling of acute liver stress during living donor liver transplantation. Am J Transplant 2006; 6: 806.
37. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31.
38. Barone S, Okaya T, Rudich S, et al. Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury. Am J Physiol Cell Physiol 2005; 289: C826.
39. Marden NY, Fiala-Beer E, Xiang SH, et al. Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 2003; 373: 669.
40. Schlossberg H, Zhang Y, Dudus L, et al. Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. Hepatology 1996; 23: 1546.
41. Marden JJ, Zhang Y, Oakley FD, et al. JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation. J Biol Chem 2008; 283: 6687.
42. Uehara T, Bennett B, Sakata ST, et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 2005; 42: 850.
43. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 2007; 97: 738.
44. Llacuna L, Mari M, Lluis JM, et al. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol 2009; 174: 1776.
45. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007; 35: 757.
46. Mas VR, Maluf DG, Stravitz R, et al. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression. Liver Transpl 2004; 10: 607.
47. Mas VR, Maluf DG, Archer KJ, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 2009; 15: 85.
48. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria; 2011. ISBN: 3-900051-07-0.
49. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289. Diseases